# Bristol-Myers Squibb Company (BMY) — Q3-2025 Earnings Results

**Report date:** 2025-10-30 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2025

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 7.09%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.63 | N/A | +10.14% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed satisfaction with the earnings beat, highlighting their commitment to innovation and shareholder value. They emphasized the importance of their ongoing projects.

**Key quotes:**

> We are pleased with our EPS performance this quarter.

> Our focus remains on delivering value through our pipeline.

### Guidance Changes

No guidance updates were provided during the earnings call.

### What It Means

Bristol Myers Squibb's strong EPS performance, exceeding expectations, has led to a positive stock reaction, with shares rising by 7.09%. This reflects investor confidence in the company's financial health and ongoing projects. However, the lack of revenue data and guidance may leave some investors cautious about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2025_